Metamizol Kern Pharma (Metamizole Magnesium)

Metamizole Kern Pharma acts on the prostaglandin pathway to provide analgesic and antipyretic effects.

• Pain: delivers rapid relief of moderate to severe acute pain.
• Fever: lowers elevated body temperature when other antipyretics are insufficient.
• Postoperative pain: assists in managing pain following surgical procedures.

• Metamizole magnesium exerts its effect primarily by inhibiting prostaglandin synthesis, likely through non‑selective cyclo‑oxygenase (COX) inhibition. This reduction in prostaglandin levels diminishes peripheral sensitisation and central pain transmission, while also lowering the hypothalamic set‑point for temperature regulation, resulting in analgesic and antipyretic actions.

Metamizole Kern Pharma may cause a range of adverse reactions.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Dizziness: transient light‑headedness.
• Hypotension: occasional drop in blood pressure, especially with rapid IV administration.
• Skin rash: mild erythema or itching.
• Elevated liver enzymes: transient laboratory changes.

Serious or Rare Side Effects

• Agranulocytosis: severe reduction in white blood cells, potentially life‑threatening.
• Anaphylactic shock: acute allergic reaction with airway compromise.
• Stevens‑Johnson syndrome: severe skin and mucous membrane disorder.
• Hemolysis: destruction of red blood cells in susceptible individuals.

Before initiating therapy, several safety considerations should be observed.

• Blood count monitoring: check complete blood count to detect agranulocytosis.
• Renal or hepatic impairment: adjust use and monitor function.
• Known hypersensitivity: avoid in patients with previous allergic reactions to metamizole.
• Elderly patients: use with caution due to increased sensitivity to hypotension.
• Pediatric use: restrict to prescribed situations and follow pediatric guidelines.
• Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Metamizole Kern Pharma can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Anticoagulants: may increase bleeding risk.
• Other NSAIDs: heightened gastrointestinal toxicity.
• Methotrexate: potential enhancement of toxicity.

Moderate Interactions (Monitor Closely)

• Antihypertensives: possible reduction of blood pressure control.
• Diuretics: may augment hypotensive effects.
• Lithium: risk of elevated lithium serum concentrations.